Clinical trial Recruiting at 1 site Interventional Ages 4 to 6

Making inhalation therapy less scary for preschool children using distraction

Official title: Effects of Two Different Distraction Methods on Fear and Anxiety Levels in Preschool Children Receiving Inhalation Treatment

Run by Ataturk University · NCT06874491 · Data updated 2026-11-12

This project will test whether a movable 3D book or a hand puppet helps 4–6-year-olds feel less afraid and anxious during their first inhalation therapy.

Quick facts

Study typeInterventional
Ages4 Years to 6 Years
SexAll
Enrollment126 (estimated)
SponsorAtaturk University
Academic / other
Locations1 site (Erzurum)
StatusRecruiting
StartedSeptember 1, 2025
Main results expectedSeptember 1, 2026
Study endsSeptember 25, 2026
Registry record updatedOctober 7, 2025
Trial IDNCT06874491 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 4–6 who are receiving inhalation therapy for the first time, have no developmental disability or chronic disease, have not used sedatives/analgesics/narcotics in the prior 24 hours, and are accompanied by a parent.

Probably not a fit

Children outside the 4–6 age range, those with developmental disabilities or chronic diseases, those with recent sedative/analgesic/narcotic use, or those who have previously received inhalation therapy are unlikely to be eligible or to benefit from these specific distraction methods.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial will compare a specially designed movable 3D book and a hand puppet as distraction methods for preschool children receiving inhalation therapy. Children aged 4–6 who receive inhalation therapy for the first time in the pediatric emergency department at Erzincan Mengücek Gazi Education and Research Hospital will be randomly assigned to one of the two intervention groups. The 3D book includes animated models of masks, nebulizers, medication vials, nurses, and the treatment environment to attract attention, while the puppet is used to provide interactive distraction during mask placement. Fear and anxiety will be measured using a questionnaire, the Child Fear Scale, and the Child Anxiety Scale-State before and after the intervention.

Why it matters

Potential benefit: If successful, these low-cost distraction tools could reduce fear and anxiety during inhalation therapy and make the procedure easier for children and caregivers.

How similar studies have gone: Similar non-pharmacological distraction methods (books, puppets, and other attention-focused techniques) have previously shown benefit in reducing procedural fear and anxiety in children, so this study builds on existing positive findings.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* -Being between 4-6 years old
* Not having a developmental disability
* Not having a history of sedative, analgesic or narcotic substance use within 24 hours before application
* Receiving inhalation therapy for the first time
* Not having a chronic disease
* Children who are accompanied by their mother or father during the procedure will be included in the study.

Exclusion Criteria:

* Being under 4 years old or over 6 years old
* having a chronic disease

Where it's running

  • Ataturk University Nursing of Faculty
    Erzurum, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.